Garrison Point Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $228K | Hold |
|
|||||
|
2025
Q1 | $176K | Hold |
|
|||||
|
2024
Q4 | $194K | Hold |
|
|||||
|
2024
Q3 | $163K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $185K | Hold |
|
|||||
|
2023
Q4 | $314K | Hold |
|
|||||
|
2023
Q3 | $209K | Hold |
|
|||||
|
2023
Q2 | $240K | Sell |
|
|||||
|
2023
Q1 | $193K | Hold |
|
|||||
|
2022
Q4 | $163K | Hold |
|
|||||
|
2022
Q3 | $168K | Hold |
|
|||||
|
2022
Q2 | $145K | Buy |
|
|||||
|
2022
Q1 | $248K | Hold |
|
|||||
|
2021
Q4 | $239K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $242K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $219K | Sell |
|
|||||
|
2020
Q1 | $202K | Sell |
|
|||||
|
2019
Q4 | $262K | Hold |
|
|||||
|
2019
Q3 | $221K | Buy |
|